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BACKGROUND Hypertrophic olivary degeneration (HOD) is a rare condition that can occur after disruption of the Guillain-Mollaret triangle. Clinically,
HOD can present with palatal myoclonus with or without oculopalatal tremor, which sometimes results in symptomatic dysphagia and/or speech
abnormalities. This condition is commonly associated with vascular lesions, with only three prior reported cases of HOD resulting from intracranial
abscess.
OBSERVATIONS An otherwise healthy patient developed multiple intracranial abscesses. Biopsy showed gram-positive cocci; however, culture
ﬁndings were negative. Polymerase chain reaction (PCR) identiﬁed Streptococcus intermedius. The patient demonstrated palatal myoclonus and
vertical nystagmus, which resulted in persistent mild dysphagia and altered speech intonation. After appropriate antimicrobial therapy with resolution of
the enhancing lesions, symptoms persisted. Follow-up imaging demonstrated progressive hypertrophy of the right olive with persistent disruption of the
right-sided rubro-olivo ﬁber pathways.
LESSONS Although HOD classically occurs after vascular insult, it can also be seen as a postinfectious sequela. Despite eradication of the infection,
palatal myoclonus and oculopalatal tremor may have a persistent impact on quality of life due to impaired speech and swallowing. This case
emphasizes the utility of universal PCR in detecting fastidious organisms as well as diffusion tensor imaging for characterization of disrupted ﬁber
pathways.
https://thejns.org/doi/abs/10.3171/CASE2265
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Hypertrophic olivary degeneration (HOD) is a rare neurological
phenomenon and is thought to occur due to the disruption of the
dento-rubro-olivary pathway, also known as the Guillain-Mollaret triangle (GMT).1 The GMT consists of the red nucleus in the midbrain,
inferior olive in the medulla, and contralateral dentate nucleus in
the cerebellum. The underlying pathology of the disruptive lesions
can be varied, and the literature has reported diverse causes,
including autoimmune, neoplastic, infarction, hemorrhage, trauma,
surgical, vascular malformations, and infectious.2 The most common
lesions are cavernous malformations, ischemic and hemorrhagic,
with infectious being the least common.2 Here we present the ﬁrst

reported case of HOD in the setting of Streptococcus intermedius
abscess.
Patients with HOD typically present with palatal tremor (PT) with
or without an ocular component consisting of an oculopalatal tremor
(OPT). PT is often described as a rhythmic contraction of the levator veli palatine unilaterally or bilaterally raising the soft palate posteriorly and superiorly in a synchronous fashion. Patients with PT
usually do not have difﬁculties with swallowing or speech and continue to experience tremors while sleeping.3 When present, the ocular component of the tremor is in sync with the palatal tremor
occurring at a 1–3-Hz frequency.3 OPT is routinely described as

ABBREVIATIONS CTT = central tegmental tract; GMT = Guillain-Mollaret triangle; HOD = hypertrophic olivary degeneration; MRI = magnetic resonance imaging;
OPT = oculopalatal tremor; PCR = polymerase chain reaction; PT = palatal tremor; SCP = superior cerebellar peduncle.
INCLUDE WHEN CITING Published June 13, 2022; DOI: 10.3171/CASE2265.
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FIG. 1. Coronal (A) and sagittal (B) contrast MRI showing multiple ringenhancing lesions consistent with intracranial abscesses. Note the largest lesion located dorsally near the junction of the pons and midbrain.

pendular nystagmus and is present in 30% of cases.1,4 PT or OPT
usually presents 2 to 48 months after initial insult, with a median of
10 months.1,5,6 However, delayed presentation of up to 8 years has
been reported in the literature.1,5 Tremors usually progressively worsen from 5 to 24 months after initial presentation and rarely improve
or completely resolve.1,7 Treatment is supportive with botulinum
toxin injections for the PT.3 OPT is more difﬁcult to treat, and gabapentin and memantine are used with some success.3
Most lesions of neuronal tracts lead to subsequent atrophy. HOD
paradoxically presents with olivary hypertrophy. The exact mechanism of this hypertrophy is not fully understood. One explanation
states that the denervation of the dento-olivary pathway releases
tonic inhibition of olivary neurons that under normal circumstances
may develop sustained synchronized oscillations.1 Histopathological
and radiological studies have demonstrated neuronal enlargement
in the setting of vacuolization of neurons with associated astrocytic
hypertrophy and gliosis with astrocytic mitochondrial proliferation in
the setting of hyperperfusion.1,8,9 The natural history of the HOD
includes initial degeneration of the olivary amiculum at 7 days

FIG. 2. A superﬁcial intracerebral encapsulated abscess taken from the
patient after a left frontal craniotomy.

followed by mild olivary enlargement, with neuronal hypertrophy at
3 weeks without glial reaction and subsequent hypertrophy of neurons and astrocytes at 8 months.1 These neuropathological ﬁndings
are concordant with radiological ﬁndings wherein the initial presentation of HOD was 1 month after the inciting lesion with T2 ﬂuidattenuated inversion recovery hyperintensity observed in the inferior
olivary nucleus, followed by olivary hypertrophy at 6 months and
resolution between 3 and 4 years.9,10

FIG. 3. Serial axial T2-weighted MRI at the level of the medulla (upper) and T1-weighted contrast MRI at the
level of the rostral pons (lower) obtained on diagnosis and up to 17 months after treatment.
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Illustrative Case
A 58-year-old female patient presented with dysarthria and palatal myoclonus. She also exhibited a mild, left-sided fourth-nerve
palsy and vertical nystagmus with a slight rotatory component. She

had a spastic gait and difﬁculty with coordination, as well as a tendency to fall backward if she closed her eyes. Magnetic resonance
imaging (MRI) revealed numerous supratentorial and infratentorial
ring-enhancing lesions demonstrating diffusion restriction, ﬁndings
concerning for abscess (Fig. 1). Blood cultures were negative.
Transesophageal echocardiography showed aortic valve vegetations. An open biopsy for a cortically based ring-enhancing lesion
was performed (Fig. 2). The initial Gram stain demonstrated grampositive cocci, but cultures showed no growth. Thus, universal polymerase chain reaction (PCR) on the tissue was performed with
detection of S. intermedius.
In the absence of an alternative source, transient bacteremia from
oral/pharyngeal colonization resulting in endocarditis and subsequent
septic emboli was presumed. No predisposing immunocompromising
conditions were found on work-up. The patient was treated with ceftriaxone, and subsequent MRI revealed resolution of the multifocal
intracranial abscesses with progressive hypertrophy of the right olive
(Fig. 3). During multiple follow-up visits over the course of nearly
2 years, the patient’s symptoms improved as she continued with
rehabilitation. However, between years 1 and 2, she plateaued with
her treatment, and her swallowing, speech, and walking worsened.

Discussion
In our case, a right-sided abscess within the dorsal midbrain–
pontine junction likely caused disruption of the ipsilateral central
tegmental tract (CTT), which in turn caused an ipsilateral HOD. The

FIG. 4. Three-dimensional reconstruction of magnetic resonance diffusion tensor imaging demonstrating the expected ﬁber tracts between
the unaffected red nucleus in the midbrain and the inferior olive complex of the medulla (left side). Note the lack of right-sided ﬁber tracts on
the side ipsilateral to the superimposed site of the abscess. Red nuclei
are colored in red, medullary olives are shown in green, and the pontine cerebral abscess at the time of diagnosis is shown in brown. Note
the reversal of sidedness as compared with conventional radiographic
imaging.

FIG. 5. An alternative view of a three-dimensional reconstruction of
magnetic resonance diffusion tensor imaging wherein the ﬁbers directly
connecting the red nuclei (red color) to the contralateral dentate nucleus
within the cerebellum (tan) are segmented. Connections with the inferior
medullary olives (green) are not highlighted in this ﬁgure. The abscess
(brown) involves the right superior cerebellar peduncle disrupting connections between the right dentate nucleus and left red nucleus.
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abscess also impacted the superior cerebellar peduncle (SCP), causing a lesser contralateral HOD. The CTT contains axonal ﬁbers
from the midbrain that project to the inferior olivary complex, thus
playing a role in motor coordination. Magnetic resonance ﬁber tracking, an imaging technology used to visualize white matter tracts on
MRI, showed disruption of the right-sided dento-olivary pathways
(Fig. 4), correlating with the right-sided olivary hypertrophy. Lesions
of this tract can cause palatal myoclonus. The SCP connects the
midbrain with the cerebellum, playing a role in coordination and
gait. Atrophy and disruption of the SCP has led to supranuclear
palsy and ataxia.11 When ﬁbers passing from the red nucleus to the
contralateral nucleus were mapped, there was disruption of the
ﬁbers passing through the SCP (Fig. 5).

Observations
Patients with HOD typically present with palatal myoclonus with
or without OPTs.3 HOD can be the result of various conditions,
including trauma, neoplasm, surgery, or abscess. In this case, HOD
was the result of an S. intermedius abscess near the dorsal midbrain–pontine junction. S. intermedius, also known as Streptococcus
milleri, is known for its tendency to cause abscesses in the brain
and liver. Review of the literature reveals three previously reported
cases of infection-related HOD: one case of toxoplasmosis and two
cases of listeria. To our knowledge, this is the ﬁrst reported case of
HOD secondary to S. intermedius. Lesion location is likely a more
signiﬁcant factor in the development of HOD than causative organism; however, more research into this rare entity is warranted.
The patient in this case developed progressive ataxia and palatal
myoclonus secondary to the HOD. Unfortunately, there was no clear
treatment for the ataxia or the palatal myoclonus. Therefore, therapies focused on management of ataxia through supportive care, such
as physical therapy and speech therapy. Certain medications have
been described for management of ataxia, including bupropion,
amantadine, riluzole, varenicline, and acetazolamide, but the marginal beneﬁts must be considered in the context of possible side
effects.12 For the palatal myoclonus, botulinum toxin injection can be
administered to the palate, and medications can be used, including
carbamazepine, lamotrigine, and sodium valproate.3 For the gazeevoked nystagmus, gabapentin or memantine can be considered.13
In our case, the patient deferred medical therapy due to the potential
side effects and elected for speech and physical therapy.
Lessons
Lesions within the GMT can result in HOD associated with disabling, chronic palatal myoclonus. Therapies should be discussed
with the patient to manage symptoms such as palatal myoclonus,
ataxia, and nystagmus—therapies that will ultimately improve the
patient’s quality of life. Most patients presenting with symptomatic
HOD will see their symptoms improve over time. The use of magnetic resonance diffusion tensor imaging has only been reported
once, and our hope is that this case may help to further illustrate
the pertinent anatomy and aid physician and patient understanding.
It may also play a role in further elucidating the complex regional
neuroanatomy involved in HOD, and we hope it may lead to more
effective treatments, such as with neuromodulation, in the future.
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